Project Description
Katie Gudiksen
Katie Gudiksen, Ph.D., is the Executive Editor for The Source on Healthcare Price and Competition. Dr. Gudiksen is an expert in healthcare reform and the drivers of healthcare costs, with a special interest in market consolidation and state policies to address market power. She has helped draft model legislation to improve state merger review processes and to prohibit anticompetitive terms in contracts between insurers and health systems. Her current work focuses on evaluating options states have to restrict excessive provider prices, including cost-growth benchmarks and state public options. Her past scholarship evaluated legal challenges to state laws aimed to improve affordability of pharmaceuticals.
Dr. Gudiksen is a graduate of the UCSF/UC Hastings Master of Science in Health Policy and Law program, where she studied policy solutions to promote competition in the pharmaceutical industry. Prior to joining The Source, she co-founded a cancer diagnostics start-up company and worked as Director of Technology where she developed technologies to detect biomarker signatures for aggressive prostate cancer. She also holds an A.M. and Ph.D. in Chemistry from Harvard University and a B.S. and B.A. from Hope College.
Considerations for state-imposed conditions on healthcare provider transactions
The Department Of Justice Withdraws ‘Outdated’ Antitrust Health Care Guidance

A Step Forward for Health Care Market Oversight: Oregon Health Authority’s Health Care Market Oversight Program
American Bar Association 2022 Antitrust Fall Forum
Taming Health Insurance Costs for Employers and Employees
Options for states to constrain pricing power of health care providers
Can Taxes Help Address High Health Care Prices?
Are State Public Option Health Plans Worth It?
Consolidation of Health Care Providers
Mitigating the Price Impacts of Health Care Provider Consolidation
State Public Option Plans — Too Modest to Improve Affordability?
State Action to Oversee Consolidation of Health Care Providers
State Efforts to Address Health Care Consolidation and Costs
High Court ERISA Ruling Frees States To Tackle Health Costs
States Risk Losing Power to Regulate Pharmacy Drug Middlemen

California’s Sutter Health Settlement: What States Can Learn About Protecting Residents from the Effects of Health Care Provider Consolidation
Preventing Anticompetitive Contracting Practices in Healthcare Markets
State Efforts to Address Health Care Consolidation and Costs
A Lesson from States: Curtailing Anticompetitive Health Care Consolidation
The skinny on the PBM case before the U.S. Supreme Court
Navigating Legal Challenges to State Efforts to Control Drug Prices